These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10320050)

  • 1. Molecular mechanisms of insulin resistance. Introduction.
    Taylor R; Brunetti P
    Exp Clin Endocrinol Diabetes; 1999; 107(2):111-2. PubMed ID: 10320050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
    Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
    Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin signalization and molecular mechanisms of insulin resistance].
    Kahn CR
    Journ Annu Diabetol Hotel Dieu; 1999; ():125-41. PubMed ID: 10732412
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin resistance and molecular abnormalities of the insulin receptor in type II diabetes].
    Clauser E; Assan R
    Journ Annu Diabetol Hotel Dieu; 1993; ():23-36. PubMed ID: 8392640
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial compartmentalization of signal transduction in insulin action.
    Baumann CA; Saltiel AR
    Bioessays; 2001 Mar; 23(3):215-22. PubMed ID: 11223878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance in type 2 diabetes as a microdomain syndrome].
    Inokuchi JI; Igarashi Y
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1179-83. PubMed ID: 12807027
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin receptor and diabetes].
    Clauser E
    Rev Prat; 1994 May; 44(9):1154-62. PubMed ID: 7939336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathogenesis of type II diabetes mellitus].
    Klein HH; Häring HU
    Internist (Berl); 1990 Mar; 31(3):168-79. PubMed ID: 2187825
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic abnormalities in the insulin receptor in non-insulin-dependent diabetes].
    Capeau J; Desbois C; Magré J
    Journ Annu Diabetol Hotel Dieu; 1993; ():37-50. PubMed ID: 8331874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin receptors, mechanism of signal transduction. Examples of abnormalities in states of insulin resistance].
    Gherzi R; Briata P
    Journ Annu Diabetol Hotel Dieu; 1993; ():11-21. PubMed ID: 8392638
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension and insulin resistance].
    Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
    Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENPP1 gene, insulin resistance and related clinical outcomes.
    Bacci S; De Cosmo S; Prudente S; Trischitta V
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine nucleotide binding regulatory proteins in liver from obese humans with and without type II diabetes: evidence for altered "cross-talk" between the insulin receptor and Gi-proteins.
    Caro JF; Raju MS; Caro M; Lynch CJ; Poulos J; Exton JH; Thakkar JK
    J Cell Biochem; 1994 Mar; 54(3):309-19. PubMed ID: 8200911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of insulin resistance.
    Müller-Wieland D; Streicher R; Siemeister G; Krone W
    Exp Clin Endocrinol; 1993; 101(1):17-29. PubMed ID: 8477820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin signaling and insulin resistance].
    Ferré P
    Therapie; 2007; 62(4):277-84. PubMed ID: 17983553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work.
    Larner J
    IUBMB Life; 2001 Mar; 51(3):139-48. PubMed ID: 11547915
    [No Abstract]   [Full Text] [Related]  

  • 20. Signaling pathways in insulin action: molecular targets of insulin resistance.
    Pessin JE; Saltiel AR
    J Clin Invest; 2000 Jul; 106(2):165-9. PubMed ID: 10903329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.